The North America Dermal Fillers Market should witness market growth of 7.0% CAGR during the forecast period (2023-2029).
The demand for cosmetic procedures, especially non-invasive ones such as dermal fillers, has experienced a consistent and significant increase in the modern business landscape. To achieve a desirable outcome, gel-like substances are administered through injections under the facial skin. These treatments are anticipated to increase the number of procedures performed as disposable income increases, particularly in emerging nations. Also, the growing understanding of filler procedures has greatly diminished the final taboos linked with cosmetic treatments. Therefore, the adoption of these items is anticipated to be strongly influenced by such changes in attitudes.
The loss of high cheekbones and retraction of the jawline can all be the results of age-related bone loss in the face. The loss of facial muscle volume and flexibility and the reduction in facial fat mobility highlights the signs of aging even more. The loss of the scaffolding supported by muscle, fat, and bone combined with the skin's eventual stretching and loss of elasticity may result in wrinkles, drooping skin, and other typical aging symptoms. As a result, dermal fillers have grown in popularity as a component of facial aesthetic operations in recent years.
The introduction of products with enhanced technology and user-friendliness, as well as additional elements, including the development of market participants in emerging nations and the rising social acceptance of aesthetic items, are projected to boost market growth throughout the projection period. Rising R&D efforts, technical advances, and rising adoption rates are driving the expansion of the market in the United States. Moreover, rising per capita healthcare and wellness spending and advancements in medical research can be linked to the market's growth. The development of the regional market is also being supported by the launch of new minimally invasive facial procedures, providing more growth opportunities for the dermal fillers market in the region.
The US market dominated the North America Dermal Fillers Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,988.4 million by 2029. The Canada market is poised to grow at a CAGR of 9.4% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 8.4% during (2023-2029).
Based on Type, the market is segmented into Biodegradable and Non-biodegradable. Based on Product, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid (PLLA), Polymethyl-methacrylate Microspheres and Others. Based on End-use, the market is segmented into MedSpa, Cosmetic Surgery Clinics and Hospitals. Based on Application, the market is segmented into Wrinkle Correction, Lip Enhancement, Facial Contouring, Scar Treatment and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.
The demand for cosmetic procedures, especially non-invasive ones such as dermal fillers, has experienced a consistent and significant increase in the modern business landscape. To achieve a desirable outcome, gel-like substances are administered through injections under the facial skin. These treatments are anticipated to increase the number of procedures performed as disposable income increases, particularly in emerging nations. Also, the growing understanding of filler procedures has greatly diminished the final taboos linked with cosmetic treatments. Therefore, the adoption of these items is anticipated to be strongly influenced by such changes in attitudes.
The loss of high cheekbones and retraction of the jawline can all be the results of age-related bone loss in the face. The loss of facial muscle volume and flexibility and the reduction in facial fat mobility highlights the signs of aging even more. The loss of the scaffolding supported by muscle, fat, and bone combined with the skin's eventual stretching and loss of elasticity may result in wrinkles, drooping skin, and other typical aging symptoms. As a result, dermal fillers have grown in popularity as a component of facial aesthetic operations in recent years.
The introduction of products with enhanced technology and user-friendliness, as well as additional elements, including the development of market participants in emerging nations and the rising social acceptance of aesthetic items, are projected to boost market growth throughout the projection period. Rising R&D efforts, technical advances, and rising adoption rates are driving the expansion of the market in the United States. Moreover, rising per capita healthcare and wellness spending and advancements in medical research can be linked to the market's growth. The development of the regional market is also being supported by the launch of new minimally invasive facial procedures, providing more growth opportunities for the dermal fillers market in the region.
The US market dominated the North America Dermal Fillers Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,988.4 million by 2029. The Canada market is poised to grow at a CAGR of 9.4% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 8.4% during (2023-2029).
Based on Type, the market is segmented into Biodegradable and Non-biodegradable. Based on Product, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid (PLLA), Polymethyl-methacrylate Microspheres and Others. Based on End-use, the market is segmented into MedSpa, Cosmetic Surgery Clinics and Hospitals. Based on Application, the market is segmented into Wrinkle Correction, Lip Enhancement, Facial Contouring, Scar Treatment and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.
Scope of the Study
By Type
- Biodegradable
- Non-biodegradable
By Product
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Polylactic Acid (PLLA)
- Polymethyl-methacrylate Microspheres
- Others
By End-use
- MedSpa
- Cosmetic Surgery Clinics
- Hospitals
By Application
- Wrinkle Correction
- Lip Enhancement
- Facial Contouring
- Scar Treatment
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bioplus Co. Ltd
- Bioxis pharmaceuticals
- Suneva Medical, Inc.
- Galderma S.A.
- Allergan PLC (AbbVie, Inc.)
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- Revance Therapeutics, Inc.
- Medytox Inc.
- Merz Pharma GmbH & Co. KGaA
- Prollenium Medical Technologies Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Dermal Fillers Market by Type
Chapter 5. North America Dermal Fillers Market by Product
Chapter 6. North America Dermal Fillers Market by End-use
Chapter 7. North America Dermal Fillers Market by Application
Chapter 8. North America Dermal Fillers Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Bioplus Co. Ltd
- Bioxis pharmaceuticals
- Suneva Medical, Inc.
- Galderma S.A.
- Allergan PLC (AbbVie, Inc.)
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- Revance Therapeutics, Inc.
- Medytox Inc.
- Merz Pharma GmbH & Co. KGaA
- Prollenium Medical Technologies Inc.
Methodology
LOADING...
